Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
boston blog main
deals
6
×
ipo
6
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
6
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
novartis
takeda pharmaceutical
biogen
cancer immunotherapy
crispr
eli lilly
fda
genentech
medicare
What
bio
roundup
pharmaceutical
deal
drugs
gene
life
medicines
millions
new
science
typically
acquisitions
aiming
alzheimer’s
ambys
announced
appetite
bails
becker
big
billions
biotech
black
brand
bread
bridgebio
butter
buyout
cancer
capital
car
cash
ceo
collabs
companies
control
covid
daniel
deadly
Language
unset
Current search:
ipo
×
deals
×
photo
×
" new york top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?